PAIA
ABBV icon

Park Avenue Institutional Advisers’s AbbVie ABBV Stock Holding History

Park Avenue Institutional Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-10,160
Closed -$629K – 11
2016
Q2 		$629K Sell
10,160
-138
-1% -$8.41K 0.54% 43
2016
Q1 		$588K Sell
10,298
-290
-3% -$16.2K 0.51% 45
2015
Q4 		$627K Sell
10,588
-423
-4% -$24.4K 0.54% 41
2015
Q3 		$599K Buy
11,011
+263
+2% +$17.1K 0.53% 42
2015
Q2 		$722K Buy
+10,748
New +$702K 0.58% 40

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Park Avenue Institutional Advisers's ABBV Position: Q3 2016 in Review

Park Avenue Institutional Advisers sold out of AbbVie (ABBV) in Q3 2016, closing a stake of 10,160 shares — an estimated $629K sold.

Park Avenue Institutional Advisers first reported a position in ABBV in Q2 2015 and held it in 5 quarters. The position peaked at $722K in Q2 2015. 1,653 funds tracked by Wall St. Rank hold ABBV as of Q3 2016.

  • Park Avenue Institutional Advisers reported no remaining AbbVie position as of Q3 2016 after selling out during the quarter.
  • Park Avenue Institutional Advisers sold 10,160 AbbVie shares in Q3 2016, an estimated $629K.
  • Park Avenue Institutional Advisers first reported a position in AbbVie in Q2 2015 and held it in 5 quarters.
  • Park Avenue Institutional Advisers's AbbVie position peaked at $722K in Q2 2015.
  • 1,653 funds tracked by Wall St. Rank held AbbVie as of Q3 2016.

Based on Park Avenue Institutional Advisers's 13F filing for Q3 2016, filed 15 Feb 2017.